TERIPARATIDE TEVA 20 microgrammes/80 microlitres, solution injectable en stylo prérempli

( ARTG ) Teriparatide LAPL is indicated for the treatment of osteoporosis in postmenopausal women and the treatment of primary osteopo​​​‍​​‍​​​​‍​​‍‍rosis in men when other agents are considered unsuitable and when there is a high risk of fractures. ,Teriparatide LAPL is indicated for the treatment of osteoporosis associated with sustained systemic glucocorticoid therapy in women and men at high risk for fracture.